Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
FITC-Concanavalin A (ConA) Conjugate: Technical Application
2026-05-25
FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose moieties on cell surfaces, streamlining workflows in immunofluorescence, flow cytometry, and glycobiology. It should only be used for carbohydrate-binding applications within its defined stability period, and is not suitable for non-carbohydrate or cross-domain targets.
-
Bestatin Stimulates Endothelial Invasion in Fibrin Matrices
2026-05-25
The reference study reveals that bestatin, an aminopeptidase inhibitor previously characterized for anti-angiogenic action, unexpectedly enhances microvascular endothelial cell invasion and tube formation in fibrin matrices. This finding challenges established assumptions about bestatin’s mechanism and highlights matrix context as critical in angiogenesis research.
-
Biotin-HPDP for Thiol-Specific Protein Labeling: Enhanced Wo
2026-05-24
Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) offers precise, reversible thiol-specific protein biotinylation ideal for redox biology, S-nitrosylation detection, and affinity purification. Learn how APExBIO's reagent streamlines experimental workflows, supports troubleshooting, and advances the study of dynamic post-translational modifications in cancer immunology and beyond.
-
13-(Substituted Benzyl) Berberrubine Derivatives: Antifungal
2026-05-23
This study demonstrates that chemical modification of berberrubine at the 13-position with substituted benzyl groups yields derivatives with markedly enhanced antifungal activity compared to their parent compounds. The findings highlight the impact of structural tuning on isoquinoline alkaloids and provide a template for rational design of new antifungal agents.
-
HyperScribe All in One mRNA Synthesis Kit Plus 1: Workflows
2026-05-22
The HyperScribe All in One mRNA Synthesis Kit Plus 1 stands out for streamlined ARCA-capped, polyadenylated mRNA synthesis with immune-evasive modifications, enabling rapid, high-yield workflows for vaccine and RNAi research. This guide translates recent breakthroughs into practical, stepwise protocols and troubleshooting advice for translational and experimental success.
-
LGK-974: Precision PORCN Inhibitor Workflows for Wnt Researc
2026-05-22
LGK-974 empowers reproducible, low-toxicity inhibition of Wnt signaling in advanced cancer models, including those with RNF43 mutations. This guide translates cutting-edge research and practical troubleshooting into actionable workflows for scientists leveraging this potent PORCN inhibitor.
-
5-Methyl-CTP: Pioneering Modified mRNA Synthesis for Next-Ge
2026-05-21
Explore how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, revolutionizes mRNA synthesis with enhanced stability and translation efficiency. This article uncovers scientific mechanisms and practical workflows that set new benchmarks for mRNA drug development.
-
Tetrahedral DNA Frameworks Enhance Enzymatic DNA Synthesis E
2026-05-21
This study introduces a highly ordered tetrahedral DNA nanostructure interface that significantly improves enzymatic oligonucleotide synthesis (EOS) efficiency and accuracy. The findings have implications for DNA data storage, synthetic biology, and precise nucleic acid detection workflows.
-
Procainamide Hydrochloride in Cardiac and Epigenetic Researc
2026-05-20
Procainamide Hydrochloride bridges cardiac sodium channel blockade with advanced epigenetic modulation, empowering both arrhythmia and DNA methylation research. This guide translates recent animal model findings and applied workflows into actionable protocols, positioning APExBIO’s reagent as a linchpin for reproducible, cross-domain experimentation.
-
FITC-Concanavalin A (ConA) Conjugate: Technical Lab Guidance
2026-05-20
FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces for immunofluorescence, flow cytometry, and glycobiology research. It should only be used for carbohydrate-binding assays under defined storage and handling conditions. This reagent is not appropriate for non-carbohydrate targets or workflows outside its specified stability window.
-
Annexin V-FITC/7-AAD Apoptosis Kit: Mechanistic Insights in
2026-05-19
Explore the Annexin V-FITC/7-AAD Apoptosis Kit for advanced apoptosis detection, with deep scientific context on mitochondrial mechanisms and recent osteosarcoma research. This article provides unique guidance for researchers seeking mechanistic clarity beyond standard cell viability assays.
-
Epalrestat: Aldose Reductase Inhibitor for Neuroprotection W
2026-05-19
Epalrestat stands out as a high-purity aldose reductase inhibitor, now pivotal in both diabetic neuropathy and Parkinson’s disease research. Its dual mechanism—targeting the polyol pathway and activating the KEAP1/Nrf2 axis—enables robust modeling of oxidative stress and neurodegeneration.
-
Deracoxib–Doxorubicin Synergy: Protecting Canine Mammary Cel
2026-05-18
This study investigates the protective role of Deracoxib, a selective COX-2 inhibitor, against doxorubicin-induced cytotoxicity in normal canine mammary epithelial cells. The findings reveal that Deracoxib reduces apoptosis and nitric oxide overproduction, suggesting a potential strategy for minimizing chemotherapy toxicity in veterinary oncology.
-
Epalrestat in Cancer Metabolism: Bridging Polyol Pathway and
2026-05-18
Explore how Epalrestat, a potent aldose reductase inhibitor, empowers advanced cancer metabolism research by targeting the polyol pathway and modulating oxidative stress. This article uniquely integrates recent oncology insights with practical assay guidance for translational scientists.
-
5-Aminolevulinic acid HCl: Enabling Heme Pathway Research
2026-05-17
5-Aminolevulinic acid HCl from APExBIO empowers advanced modeling of heme biosynthesis, immune evasion, and cancer metabolism. Discover detailed protocols, troubleshooting tips, and experimental insights for both infection and oncology research.